The Fenom Pro® point-of-care breath analyzer measures Fractional Exhaled Nitric Oxide (FeNO) molecules. FeNO is an objective biomarker of allergic airway inflammation, an indicator of asthma and other pulmonary conditions. FeNO testing is recommended in the ATS guidelines. Accurate measurement of FeNO levels helps healthcare professionals to correctly prescribe medicines and adjust treatments to reduce exacerbations – providing better overall care to their patients.
FeNO testing has never been easier. For additional information visit fenomasthma.com
Please note, all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative. The information provided in this site is intended for healthcare professionals.
The Latest News From Vyaire
CHICAGO – May 14, 2020 – Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, announced today that Vyaire has been selected by the European Commission as a supplier of priority medical equipment to help address the COVID-19 pandemic.Read More
CHICAGO and WICHITA, KAN.,– May 4, 2020 – Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, together with Spirit AeroSystems [NYSE: SPR], announced today a new manufacturing and supply collaboration to build critical care ventilatorsRead More